Long-term prescription opioids ‘up later hep C risk threefold’
Findings from a big data-linkage study have implications for public health interventions, researchers say.
Tag: Hepatitis
Doctors decry ‘stigmatising’ social media posts by federal police
The text and graphics used in the AFP campaign perpetuate stereotypes of drug users and are not evidence based, they say.
Biopsy ‘may delay recovery’ from hepatitis due to immunotherapy
Empiric therapy may be appropriate in many cases, researchers say.
Is it ethical to offer patients cash to boost hep C treatment?
A fresh approach is needed if Australia is to stamp out hepatitis C in the next decade, he says.
DAAs drive down liver transplant rate: First study
Universal access to the antivirals appears to have turned the tide of hepatis C-related transplantation, gastroenterologists say.
Hep C case studies: a GP guide to diagnosis and cure
HCV expert consults with three actual patients
Missed opportunity: How to manage hep C patients who get reinfected
Q&A with A/Prof Simone Strasser, immediate past president of the Gastroenterological Society of Australia
Consider aspirin prophylaxis for liver cancer: Aus researchers
Hepatologists have pooled the evidence on the pros and cons for high-risk patients.
Odds of hep C recurrence ‘low’ after achieving SVR, even in high-risk groups
Patients treated with direct-acting antivirals are more likely to acquire a new infection than relapse, data show.
The hep C revolution breaking out inside Australia’s prisons
After 20 years of work, Professor Andrew Lloyd says it can.
